{"nctId":"NCT00344175","briefTitle":"Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors","startDateStruct":{"date":"2006-06"},"conditions":["Hypercholesterolemia","Dyslipidemia","Coronary Heart Disease"],"count":178,"armGroups":[{"label":"Pitavastatin 4 mg","type":"EXPERIMENTAL","interventionNames":["Drug: pitavastatin"]},{"label":"Simvastatin 40mg/80mg","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: simvastatin"]}],"interventions":[{"name":"pitavastatin","otherNames":[]},{"name":"simvastatin","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Completed NK-104-304 (NCT 00309738)\n* Hypercholesterolemia or combined dyslipidemia\n* 2 or more risk factors for coronary heart disease (CHD)\n\nExclusion Criteria:\n\n* Withdrawn or terminated from NK-104-304 (00309738)","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Patients Attaining NCEP LDL-C Target at Week 16","description":"Number of patients attaining the National Cholesterol Education Program (NCEP) LDL-C target at Week 16. According to NCEP criteria the target LDL-C is 100 mg/dL.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"98","spread":null},{"groupId":"OG001","value":"45","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Patients Attaining NCEP LDL-C Target at Week 44","description":"Number of patients attaining National Cholesterol Education Program (NCEP) LDL-C target at Week 44. According to NCEP criteria the target LDL-C is 100 mg/dL.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"94","spread":null},{"groupId":"OG001","value":"42","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in LDL-C","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-41.81","spread":"15.130"},{"groupId":"OG001","value":"-41.37","spread":"16.425"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":121},"commonTop":["Nasopharyngitis","Back pain","Myalgia","Influenza","Arthralgia"]}}}